MacroGenics
MGNX
132 hedge funds and large institutions have $949M invested in MacroGenics in 2018 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 46 increasing their positions, 27 reducing their positions, and 18 closing their positions.
89% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 18
70% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 27
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
49% more capital invested
Capital invested by funds: $638M → $949M (+$310M)
11% more funds holding
Funds holding: 119 → 132 (+13)
10.81% more ownership
Funds ownership: 91.35% → 102.17% (+11%)
55% less call options, than puts
Call options by funds: $136K | Put options by funds: $302K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$54.9M |
| 2 |
Millennium Management
New York
|
+$10.1M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$8.55M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$7.53M |
| 5 |
6CM
683 Capital Management
New York
|
+$6.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.55M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
-$5.19M |
| 3 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
-$5.11M |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$3.95M |
| 5 |
TM
Tiger Management
New York
|
-$2.43M |
MGNX Hedge Fund Activity: Q1 2018 in Review
132 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q1 2018, worth a combined $949M — up 49% from $638M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new MGNX positions and 18 closed out — a net gain of 16 holders — while 46 added to existing stakes and 27 trimmed.
The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $54.9M. The largest seller was Fidelity Investments, cutting an estimated $5.55M.
- 132 institutional investors held MacroGenics (MGNX) as of Q1 2018, up from 119 in Q4 2017.
- Funds reported $949M of MacroGenics stock for Q1 2018, up 49% quarter-over-quarter.
- 34 funds opened new MacroGenics positions in Q1 2018 and 18 closed out, a net change of +16 holders.
- The largest MacroGenics buyer in Q1 2018 was T. Rowe Price Associates, an estimated $54.9M added.
- The largest MacroGenics seller in Q1 2018 was Fidelity Investments, an estimated $5.55M sold.
Based on aggregated 13F filings for Q1 2018.